Terms: = Prostate cancer AND RSPO3, Q9BXY4, THSD2, PWTSR, FLJ14440, CRISTIN1, ENSG00000146374, 84870
6 results:
1. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulation of cancer genes by recurrent intergenic fusions.
Yun JW; Yang L; Park HY; Lee CW; Cha H; Shin HT; Noh KW; Choi YL; Park WY; Park PJ
Genome Biol; 2020 Jul; 21(1):166. PubMed ID: 32631391
[TBL] [Abstract] [Full Text] [Related]
3. Regenerative potential of prostate luminal cells revealed by single-cell analysis.
Karthaus WR; Hofree M; Choi D; Linton EL; Turkekul M; Bejnood A; Carver B; Gopalan A; Abida W; Laudone V; Biton M; Chaudhary O; Xu T; Masilionis I; Manova K; Mazutis L; Pe'er D; Regev A; Sawyers CL
Science; 2020 May; 368(6490):497-505. PubMed ID: 32355025
[TBL] [Abstract] [Full Text] [Related]
4. rspo3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.
Mesci A; Lucien F; Huang X; Wang EH; Shin D; Meringer M; Hoey C; Ray J; Boutros PC; Leong HS; Liu SK
J Transl Med; 2019 Apr; 17(1):125. PubMed ID: 30987640
[TBL] [Abstract] [Full Text] [Related]
5. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract] [Full Text] [Related]
6. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract] [Full Text] [Related]
